Evidence map›Paper›PMID 34993198›Full record

ReviewFrontiers in cell and developmental biology2021

m6A Methylation Regulates Osteoblastic Differentiation and Bone Remodeling.

Mei Huang, Shaozhe Xu, Lifei Liu, Miao Zhang, Jianmin Guo, Yu Yuan, Jiake Xu, Xi Chen, Jun Zou

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Identification and validation ofBiomolecules & biomedicine · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mei HuangSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Shaozhe XuSchool of Sports Science, Wenzhou Medical University, Wenzhou, China.
Lifei LiuSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Miao ZhangSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Jianmin GuoSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Yu YuanSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Jiake XuSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Xi ChenSchool of Sports Science, Wenzhou Medical University, Wenzhou, China.
Jun ZouSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Shanghai University of Sport · CNWenzhou Medical University · CNUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is a prevalent bone disease of the aging population, which is characterized by a decrease in bone mass because of the imbalance of bone metabolism. Although the prevention and treatment of osteoporosis have been explored by different researchers, the mechanisms underlying osteoporosis are not clear exactly. N6 methyladenosine (m6A) is a methylated adenosine nucleotide, which functions through its interaction with the proteins called "writers," "readers" and "erasers." The epigenetic regulation of m6A has been demonstrated to affect mRNA processing, nuclear export, translation, and splicing. At the cellular level, m6A modification has been known to affect cell proliferation, differentiation, and apoptosis of bone-related cells, such as bone marrow mesenchymal stem cells (BMSC), osteoblasts, and osteoclasts by regulating the expression of ALP, Runx2, Osterix, VEGF, and other related genes. Furthermore, PTH/Pth1r, PI3K-Akt, Wnt/β-Catenin, and other signaling pathways, which play important roles in the regulation of bone homeostasis, are also regulated by m6A. Thus, m6A modification may provide a new approach for osteoporosis treatment. The key roles of m6A modification in the regulation of bone health and osteoporosis are reviewed here in this article.

Indexed as

bone marrow mesenchymal stem cellsbone remodelingm6A methylationosteoporosissignaling pathways

Identifiers

PMID34993198
PMCPMC8724434
OpenAlexW4200403638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.